Inbal Mishalian

3.1k total citations · 1 hit paper
26 papers, 2.4k citations indexed

About

Inbal Mishalian is a scholar working on Immunology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Inbal Mishalian has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Inbal Mishalian's work include Immune cells in cancer (13 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers) and Immune Response and Inflammation (6 papers). Inbal Mishalian is often cited by papers focused on Immune cells in cancer (13 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers) and Immune Response and Inflammation (6 papers). Inbal Mishalian collaborates with scholars based in Israel, United States and United Kingdom. Inbal Mishalian's co-authors include Zvi G. Fridlender, Liran Levy, Janna Michaeli, Zvi Granot, Lida Zolotarov, Sunil Singhal, Steven Μ. Albelda, Avi‐Hai Hovav, Ronit Vogt Sionov and Jing Sun and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Inbal Mishalian

26 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer

2015 622 citations Jitka Yehudith Sagiv, Janna Michaeli et al. Cell Reports profile →

Peers

Countries citing papers authored by Inbal Mishalian

Since Specialization

Citations

This map shows the geographic impact of Inbal Mishalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inbal Mishalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inbal Mishalian more than expected).

Fields of papers citing papers by Inbal Mishalian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inbal Mishalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inbal Mishalian. The network helps show where Inbal Mishalian may publish in the future.

Co-authorship network of co-authors of Inbal Mishalian

This figure shows the co-authorship network connecting the top 25 collaborators of Inbal Mishalian. A scholar is included among the top collaborators of Inbal Mishalian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inbal Mishalian. Inbal Mishalian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data 2024 ·Cells ·(unknown), (unknown), (unknown), Revital Aricha, Inbal Mishalian, (unknown), Matthew Frankel, John M. Lawler, Francesca Saffioti, Massimo Pinzani, Douglas Thorburn, Amnon Peled, Adi Mor, Ilan Vaknin	8
2	Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics 2023 ·Frontiers in Immunology ·(unknown), Stefano Caruso, Clément Meiller, Inbal Mishalian, Théo Z. Hirsch, Quentin Bayard, Carmit T. Tadmor, Hanna Wald, Didier Jean, Ori Wald	2
3	Tumor-Associated Neutrophils Drive B-cell Recruitment and Their Differentiation to Plasma Cells 2021 ·Cancer Immunology Research ·Merav E. Shaul, (unknown), (unknown), (unknown), Ludovica Arpinati, (unknown), (unknown), Inbal Mishalian, Zvi G. Fridlender	29
4	CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model. 2020 ·Journal of Hepatology ·Neta Barashi, Michal Segal, (unknown), (unknown), Adi Mor, Inbal Mishalian, Devorah Olam, Amnon Peled, Francesca Saffioti, Douglas Thorburn	1
5	Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance 2020 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michal Abraham, Inbal Mishalian, (unknown), Tamar Katz, (unknown), Shai Yarkoni, (unknown), Amnon Peled, Tsila Zuckerman, Jerry Stein	2
6	VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice 2019 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), Inbal Mishalian, Eli Pikarsky, Froma Oberman, Zvi G. Fridlender, Joel K. Yisraeli	22
7	Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers 2017 ·Clinical Cancer Research ·Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, (unknown), Orly Eizenberg, Katia Beider, Arnon Nagler, (unknown), (unknown), (unknown), Eithan Galun, Yoseph Caraco, Reuven Or, Amnon Peled	41
8	Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs 2016 ·OncoImmunology ·Merav E. Shaul, Liran Levy, Jing Sun, Inbal Mishalian, Sunil Singhal, Veena Kapoor, Wen-Hwai Horng, (unknown), Steven Μ. Albelda, Zvi G. Fridlender	197
9	The diversity of circulating neutrophils in cancer 2016 ·Immunobiology ·Inbal Mishalian, Zvi Granot, Zvi G. Fridlender	113
10	Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response 2015 ·OncoImmunology ·Liran Levy, Inbal Mishalian, (unknown), Lida Zolotarov, Janna Michaeli, Zvi G. Fridlender	49
11	Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer breakdown → 2015 ·Cell Reports ·Jitka Yehudith Sagiv, Janna Michaeli, Simaan Assi, Inbal Mishalian, (unknown), Liran Levy, (unknown), (unknown), Lola Polyansky, Ronit Vogt Sionov, Amiram Ariel, Avi‐Hai Hovav, Erik Henke, Zvi G. Fridlender, Zvi Granot	622
12	Isolation and Characterization of Neutrophils with Anti-Tumor Properties 2015 ·Journal of Visualized Experiments ·Ronit Vogt Sionov, Simaan Assi, Maya Gershkovitz, Jitka Yehudith Sagiv, Lola Polyansky, Inbal Mishalian, Zvi G. Fridlender, Zvi Granot	11
13	Using macrophage activation to augment immunotherapy of established tumours 2013 ·British Journal of Cancer ·Zvi G. Fridlender, Arminder S. Jassar, Inbal Mishalian, (unknown), Varun Kapoor, (unknown), Jing Sun, Sunil Singhal, Liran Levy, Steven Μ. Albelda	53
14	Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression 2013 ·Cancer Immunology Immunotherapy ·Inbal Mishalian, (unknown), Liran Levy, Lida Zolotarov, Janna Michaeli, Zvi G. Fridlender	275
15	Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils 2012 ·PLoS ONE ·Zvi G. Fridlender, Jing Sun, Inbal Mishalian, Sunil Singhal, Guanjun Cheng, Veena Kapoor, Wen-Hwai Horng, (unknown), (unknown), G. Scott Worthen, Steven Μ. Albelda	241
16	Recruited Macrophages Control Dissemination of Group A Streptococcus from Infected Soft Tissues 2011 ·The Journal of Immunology ·Inbal Mishalian, (unknown), Amnon Peled, Alexander Maly, (unknown), Miriam Ravins, Tegest Aychek, Steffen Jung, Emanuel Hanski	41
17	Functional Analysis of the Quorum-Sensing Streptococcal Invasion Locus (sil) 2009 ·PLoS Pathogens ·Ilia Belotserkovsky, Moshe Baruch, Asaf Peer, (unknown), Miriam Ravins, Inbal Mishalian, (unknown), Yoav Smith, Emanuel Hanski	37
18	The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing 2008 ·Cell Host & Microbe ·Annelies S. Zinkernagel, Anjuli M. Timmer, Morgan A. Pence, Jeffrey B. Locke, John T. Buchanan, Claire E. Turner, Inbal Mishalian, Shiranee Sriskandan, Emanuel Hanski, Victor Nizet	145
19	Transcriptional regulation of the sil locus by the SilCR signalling peptide and its implications on group A streptococcus virulence 2007 ·Molecular Microbiology ·(unknown), (unknown), Moshe Baruch, Ilia Belotserkovsky, (unknown), Inbal Mishalian, Andreas Podbielski, Bernd Kreikemeyer, Emanuel Hanski	40
20	A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues 2006 ·The EMBO Journal ·Carlos Hidalgo‐Grass, Inbal Mishalian, Mary Dan‐Goor, Ilia Belotserkovsky, (unknown), Victor Nizet, Amnon Peled, Emanuel Hanski	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact